- Home
- WPM vs EW Comparison
WPM vs EW Comparison
Compare WPM & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPM
- EW
- Stock Information
- Founded
- WPM 2004
- EW 1958
- Country
- WPM Canada
- EW United States
- Employees
- WPM N/A
- EW N/A
- Industry
- WPM Precious Metals
- EW Industrial Specialties
- Sector
- WPM Basic Materials
- EW Health Care
- Exchange
- WPM Nasdaq
- EW Nasdaq
- Market Cap
- WPM 38.5B
- EW 44.6B
- IPO Year
- WPM 2004
- EW 2000
- Fundamental
- Price
- WPM $86.70
- EW $78.20
- Analyst Decision
- WPM Strong Buy
- EW Buy
- Analyst Count
- WPM 9
- EW 20
- Target Price
- WPM $84.89
- EW $80.20
- AVG Volume (30 Days)
- WPM 1.8M
- EW 4.5M
- Earning Date
- WPM 05-08-2025
- EW 07-23-2025
- Dividend Yield
- WPM 0.76%
- EW N/A
- EPS Growth
- WPM 4.62
- EW 200.69
- EPS
- WPM 1.36
- EW 7.02
- Revenue
- WPM $1,458,244,000.00
- EW $5,522,300,000.00
- Revenue This Year
- WPM $38.25
- EW $11.68
- Revenue Next Year
- WPM $2.93
- EW $9.50
- P/E Ratio
- WPM $63.37
- EW $32.32
- Revenue Growth
- WPM 32.76
- EW 8.23
- 52 Week Low
- WPM $51.96
- EW $58.93
- 52 Week High
- WPM $87.42
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- WPM 60.38
- EW 63.10
- Support Level
- WPM $84.46
- EW $74.20
- Resistance Level
- WPM $87.12
- EW $78.75
- Average True Range (ATR)
- WPM 1.85
- EW 1.48
- MACD
- WPM 0.40
- EW -0.01
- Stochastic Oscillator
- WPM 96.41
- EW 89.15
About WPM Wheaton Precious Metals Corp (Canada)
Wheaton Precious Metals Corp is a precious metal streaming company. The company metal streaming company which generates its revenue primarily from the sale of precious metals (gold, silver and palladium) and cobalt. Its reportable segment includes: Gold, Silver, Palladium, Platinum, Cobalt, and Other.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.